These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 1915450

  • 1. Myocardial catecholamine concentrations in dilated cardiomyopathy and heart failure of different origins.
    Regitz V, Leuchs B, Bossaller C, Sehested J, Rappolder M, Fleck E.
    Eur Heart J; 1991 Aug; 12 Suppl D():171-4. PubMed ID: 1915450
    [Abstract] [Full Text] [Related]

  • 2. [Myocardial catecholamine content in heart failure--II: Measurement in endomyocardial biopsies, reference systems, normal values].
    Regitz V, Sasse S, Fleck E.
    Z Kardiol; 1989 Dec; 78(12):759-63. PubMed ID: 2623917
    [Abstract] [Full Text] [Related]

  • 3. [Myocardial catecholamine content in heart failure--I: Regional distribution in explanted hearts. Comparison between dilated cardiomyopathy and coronary heart disease].
    Regitz V, Sasse S, Bossaller C, Strasser R, Schüler S, Hetzer R, Fleck E.
    Z Kardiol; 1989 Dec; 78(12):751-8. PubMed ID: 2623916
    [Abstract] [Full Text] [Related]

  • 4. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 5. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
    Regitz V, Fleck E.
    Am J Cardiol; 1992 Jun 15; 69(19):1574-80. PubMed ID: 1598872
    [Abstract] [Full Text] [Related]

  • 6. Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases.
    Regitz V, Shug AL, Fleck E.
    Am J Cardiol; 1990 Mar 15; 65(11):755-60. PubMed ID: 2316456
    [Abstract] [Full Text] [Related]

  • 7. Relationship between myocardial norepinephrine content and left ventricular function--an endomyocardial biopsy study.
    Schofer J, Tews A, Langes K, Bleifeld W, Reimitz PE, Mathey DG.
    Eur Heart J; 1987 Jul 15; 8(7):748-53. PubMed ID: 3653125
    [Abstract] [Full Text] [Related]

  • 8. Atrial and vascular oxidative stress in patients with heart failure.
    Rochette L, Tatou E, Maupoil V, Zeller M, Cottin Y, Jazayeri S, Brenot R, Girard C, David M, Vergely C.
    Cell Physiol Biochem; 2011 Jul 15; 27(5):497-502. PubMed ID: 21691067
    [Abstract] [Full Text] [Related]

  • 9. Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study.
    Kawai C, Yui Y, Hoshino T, Sasayama S, Matsumori A.
    J Am Coll Cardiol; 1983 Nov 15; 2(5):834-40. PubMed ID: 6685149
    [Abstract] [Full Text] [Related]

  • 10. Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy.
    Cabiati M, Svezia B, Matteucci M, Botta L, Pucci A, Rinaldi M, Caselli C, Lionetti V, Del Ry S.
    PLoS One; 2016 Nov 15; 11(8):e0160110. PubMed ID: 27479215
    [Abstract] [Full Text] [Related]

  • 11. Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy.
    Kobayashi M, Izawa H, Cheng XW, Asano H, Hirashiki A, Unno K, Ohshima S, Yamada T, Murase Y, Kato TS, Obata K, Noda A, Nishizawa T, Isobe S, Nagata K, Matsubara T, Murohara T, Yokota M.
    JACC Cardiovasc Imaging; 2008 Nov 15; 1(6):718-26. PubMed ID: 19356507
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: downregulation in heart failure.
    Regitz-Zagrosek V, Fielitz J, Dreysse R, Hildebrandt AG, Fleck E.
    Cardiovasc Res; 1997 Jul 15; 35(1):99-105. PubMed ID: 9302352
    [Abstract] [Full Text] [Related]

  • 13. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA, Neglia D, L'Abbate A.
    J Cardiovasc Med (Hagerstown); 2008 Aug 15; 9(8):778-82. PubMed ID: 18607240
    [Abstract] [Full Text] [Related]

  • 14. Myocardial catecholamines in primary heart muscle disease: fact or fancy?
    Seferović PM, Maksimović R, Ostojić M, Stepanović S, Nikolić J, Vasiljević JD, Kanjuh V, Seferović D, Simeunović S, Ristić A.
    Eur Heart J; 1995 Dec 15; 16 Suppl O():124-7. PubMed ID: 8682078
    [Abstract] [Full Text] [Related]

  • 15. [Myocardial noradrenaline content: a factor not considered up to now for the prognosis of patients with dilated cardiomyopathy].
    Schofer J, Tews A, Rühwedel H, Reimitz PE, Mathey DG.
    Z Kardiol; 1989 Jun 15; 78(6):366-71. PubMed ID: 2756732
    [Abstract] [Full Text] [Related]

  • 16. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy.
    Nagueh SF, Shah G, Wu Y, Torre-Amione G, King NM, Lahmers S, Witt CC, Becker K, Labeit S, Granzier HL.
    Circulation; 2004 Jul 13; 110(2):155-62. PubMed ID: 15238456
    [Abstract] [Full Text] [Related]

  • 17. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T, Naya M, Manabe O, Wakasa S, Kubota S, Chiba S, Iwano H, Yamada S, Yoshinaga K, Tamaki N, Tsutsui H, Matsui Y.
    JACC Cardiovasc Imaging; 2011 Jul 13; 4(7):762-70. PubMed ID: 21757167
    [Abstract] [Full Text] [Related]

  • 18. Intramyocardial adrenergic activation in chagasic cardiomyopathy and coronary artery disease.
    Nastari L, Ramires FJ, Salemi VM, Ianni BM, Fernandes F, Strunz CM, Arteaga E, Mady C.
    Arq Bras Cardiol; 2011 Feb 13; 96(2):99-106. PubMed ID: 21180891
    [Abstract] [Full Text] [Related]

  • 19. Sympathetic activity in idiopathic dilated cardiomyopathy. Influence of captopril and hydralazine.
    Schofer J, Bleifeld W.
    Cardiovasc Drugs Ther; 1987 Aug 13; 1(2):177-81. PubMed ID: 3154321
    [Abstract] [Full Text] [Related]

  • 20. Myocardial insufficiency is related to reduced subunit 4 content of cytochrome c oxidase.
    Vogt S, Ruppert V, Pankuweit S, Paletta JPJ, Rhiel A, Weber P, Irqsusi M, Cybulski P, Ramzan R.
    J Cardiothorac Surg; 2018 Sep 17; 13(1):95. PubMed ID: 30223867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.